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Abstract
Many epithelia express specific Na+ channels (ENaC) together with the cystic fibrosis regulator (CFTR) Cl channels. Pancreatic ducts
secrete HCO3
-rich fluid and express CFTR. However, the question whether they possess ENaC has not been consistently addressed. The aim
of the present study was to investigate if pancreatic ducts express functional ENaC. Membrane voltages (V) of ducts isolated from rat
pancreas were measured with microelectrodes or whole-cell patch-clamp technique. Amiloride and benzamil given from bath or luminal sides
did not hyperpolarize V. Lowering of extracellular Na+ concentrations had effects that were not consistent with a simple Na+ conductance, but
rather with a Na+/Ca2 + exchange. Acute or long-lasting treatment of pancreatic ducts with mineralocorticoids had no effect on V of
unstimulated or secretin-stimulated preparations. Furthermore, pre-treatment of animals with glucocorticoids had no effect on pancreatic fluid
secretion evoked from ducts, or from acini. Hence, our study shows that pancreas especially pancreatic ducts do not express functional ENaC.
D 2002 Elsevier Science B.V. All rights reserved.
Keywords: ENaC; Na+ channel; Cystic fibrosis regulator; Pancreas; Pancreatic duct; Steroid hormone
1. Introduction
The first step in the transepithelial Na+ transport is the
passive electrodiffusion through the apical membrane and
subsequent Na+ extrusion by the basolateral pump. This
concept, developed by Ussing et al. in the seminal studies
of the frog skin laid grounds and impetus to the field of
experimental epithelial physiology (see E.H. Larsen, this
volume). Absorption of Na+ against a large concentration
gradient is a task of several epithelia, such as those lining
the distal nephron, colon, ducts of salivary and sweat glands
and toad bladder. These tight epithelia, responsive to mine-
ralocorticoids, are involved in salt and water balance [1,2].
In other epithelia, for example those lining upper respiratory
pathways and lung, Na+ transport is not involved in overall
salt balance, but in maintaining hydration of the mucosa
and keeping the alveoli dry. The Na+ channel responsible
for mediation of electrodiffusion across the apical mem-
branes of these epithelia is highly selective for Na+ and
sensitive to amiloride. This epithelial Na+ channel (ENaC)
has been molecularly characterized as a hetero-oligomeric
protein consisting of subunits a-ENaC, h-ENaC and g-
ENaC, probably in a a2hg constellation [1,3,4].
In several epithelia (intestine, kidney, respiratory epithe-
lia), ENaC is expressed along with the cystic fibrosis trans-
membrane regulator (CFTR) Cl channel, and in many
cases, there seems to be a reciprocal control of these
channels, such that an epithelium can switch between
secretion and absorption. For example, when the CFTR-
Cl channel is stimulated, ENaC is inhibited and thus Cl
and fluid secretion prevails. In cystic fibrosis (CF), where
CFTR is defective, Na+ absorption dominates in respiratory
epithelia, resulting in dehydration of the mucous surface
[5,6]. However, the research field of CFTR–ENaC inter-
actions is quite controversial, and in some co-expression
studies, there are indications that ENaC can stimulate CFTR
activity [7,8]. There are many studies addressing the ques-
tion of these complex interactions between CFTR and
ENaC. The proposals include protein–protein interactions,
involvement of PDZ domain proteins, cytoskeletal proteins,
control of exocytosis, G-proteins and other regulatory pro-
teins, such as Nedd4 that are sensitive to intracellular Na+
(and Cl) [9–12]. Notably in absorptive epithelia, such as
sweat and salivary ducts that also express ENaC and CFTR,
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Na+ and Cl transport is electrically coupled and regulated
in parallel [12–15]. This speaks for more flexible, perhaps
tissue-specific control pathways for regulation of Na+ and
Cl permeabilities.
Pancreas is one of the main organs affected by CF, and
the primary defect is in HCO3
 secretion that is dependent
on CFTR. Bicarbonate secretion originates in pancreatic
ducts and the apical membrane of intralobular ducts is lined
with CFTR that can function as a Cl channel [16–19].
Although the native ductal epithelium is not a tight epithe-
lium [20], and thus would not fit with most steroid-regulated
epithelia, the question of Na+ channels is not settled. In our
earlier electrophysiological work on rat pancreatic ducts,
where we studied CFTR-Cl channels and K+ channels,
analysis of fractional conductances indicated that there was
a small cation conductance, but it was not immediately
recognizable as due to Na+ channels [16,20]. Nevertheless,
it was shown that pancreas, along with brain, testis, and
ovary, contains transcripts for a y-ENaC subunit [21]. In
expression systems, y-ENaC together with h and g subunits
can form Na+ channels that have a slightly lower selectivity
for Na+ over Li+, and 30 lower sensitivity to amiloride
compared to the ahg-ENaC [21]. Whether yhg-ENaC
occurs in vivo is not clear. Moreover, transcripts for human
ENaC were detected in human pancreas [22], and recent
immunohistochemical studies on rat pancreas show that
there is expression of a-, h- and g-ENaC subunits in the
apical membrane of pancreatic acini and intercalated ducts
(Jeppe Praetorius, personal communication).
Therefore, the aim of the present study was to investigate
whether there are functional Na+ channels in rat pancreatic
ducts. For this purpose, we perfused intra- and interlobular
pancreatic ducts and measured cell voltages with micro-
electrodes, and in smaller intercalated and intralobular ducts,
cell voltages were measured with a whole-cell patch-clamp
technique. In addition, we investigated effects of mineralo-
corticoids and glucocorticoids on membrane voltages and
also monitored secretion from intact pancreas in in vivo
preparations.
2. Materials and methods
2.1. In vitro preparations
Pancreatic tissue was obtained from female Wistar rats
(100–300 g), which were kept on a standard laboratory
diet. In some experiments, small intra- and interlobular
ducts were isolated by microdissection and perfused in
vitro, as described previously [23]. Dissected ducts (o.d.
20–60 Am) were held between two holding pipettes and
placed in a perfusion chamber mounted on a stage of an
inverted microscope (Axiovert 10, Zeiss, Germany). The
ducts were bathed in a control bicarbonate containing
solution of the following composition (in mmol/l): Na+
145, K+ 3.6, Ca2 + 1.5, Mg2 + 1, Cl 125, HCO3
 25,
phosphate 2 and glucose 5. The pH was equilibrated to 7.4
with 5% CO2 in O2. The lumen of the ducts was perfused
through the double-barrelled pipette with a HCO3
-free
medium where HCO3
 was replaced with gluconate. Indi-
vidual cells were impaled with KCl-filled electrodes (100–
200 MV) from the basolateral side of perfused ducts and
the voltage across the basolateral membrane (Vbl) was
measured with respect to the grounded bath as described
previously [23].
For patch-clamp experiments, pancreatic ducts were
obtained from collagenase digests of rat pancreas as
described previously [24]. Briefly, pancreas cut into small
pieces was incubated with collagenase V (1.3 mg/ml) in
DMEM 1000/nutrient mixture F12 (HAM) medium mix
containing trypsin inhibitor (0.17 mg/ml). Single interca-
lated and small intralobular duct fragments (o.d. 10–40
Am) were identified with the aid of a dissection microscope
and later in an inverted microscope (Axiovert 100TV,
Zeiss). Suction pipettes held ducts placed in a perfusion
chamber such that both luminal and the basolateral sides of
the epithelium were accessible to the bathing solutions.
The cell responses were monitored in whole-cell nystatin
patch-clamp recordings adopted for pancreatic ducts [24].
Patch pipettes had resistances of about 5 MV and the
initial seal was at least 1 GV. The cell membrane under the
pipette was permeabilized to make direct electrical access
to duct cells. Nystatin (0.02–0.1 mmol/l) was dissolved in
a pipette solution adjusted to pH 7.2 that had the following
composition (mmol/l): Na+ 11, K+ 125, Cl 32, gluconate
96, Mg2 + 1, phosphate 6, glucose 5, adenosine 5V-tripho-
spate (ATP) 1, and Ca2 + was adjusted to 0.1 AM with
EGTA. A flowing 1-M KCl electrode was used as a
reference. The membrane voltage (Vm) was continuously
monitored during experiments in a current-clamp mode
(zero current-clamp). Periodically, the whole-cell current
(I) was measured in a voltage-clamp mode of the patch-
clamp amplifier (EPC 9, Heka, Germany).
The chambers were continuously perfused at a rate of
10–15 ml/min with control solutions as given above. The
temperature was kept constant at 37jC during all experi-
ments. In some experiments, Cl concentrations were
decreased from 125 to 32 or 5 mM and replaced with
gluconate. In other experiments, Na+ was decreased to 0
or 5 mM Na+ and replaced with N-methyl-D-glucamine
(NMDG+) titrated with HCl, or in a few experiments
with Li+. Ca2 +-free solutions were made by adding 1 or
5 mM EGTA to solutions. The following transport
inhibitors and agonists were used: amiloride (RBI,
Research Chemicals), benzamil (Molecular Probes) and
aldosterone, secretin, cholecystokinin octapeptide (CCK8)
and ATP (Sigma).
2.2. In vivo preparations
For several experiments where pancreatic secretion
was monitored, in vivo preparation of pancreas was
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performed. The necessary permission was obtained from
the Danish Animal Ethical Committee. Female Wistar rats
weighing 100–300 g were used. In one series of experi-
ments, animals were injected intramuscularly for 4–9
days with 50 mg/kg body weight of deoxycorticosterone
pivolate (DOC) (Sigma). In another series of experiments,
animals were injected intraperitoneally for 2 days with 10
mg/kg body weight of dexamethasone (Dexa) (Sigma).
Control and treated animals were fasted 16–24 h before
experiments. Rats were anesthetized with Mebumal (pen-
tobarbital, 40 mg/kg i.p.; Nycomed-DAK) and the facial
vein was cannulated for infusions. Anesthesia was main-
tained during the experiments by additional, intravenous
injections of Mebumal. A thermostatically controlled
heating table was used to maintain the animal’s body
temperature at 38jC. The animals were tracheostomized
and the abdomen was opened by a midline incision. The
pylorus and the proximal end of the bile duct were
ligated. A polyethylene tube was inserted into the com-
mon pancreatic bile duct. Collection of pancreatic juice
was started with a control period of 30–60 min during
which a mix of DMEM 1000/F12 (HAM) medium
(Gibco) was infused. Secretion was then stimulated by
infusion of secretin (10 pmol/min/animal) and subse-
quently, after a period without an agonist, by infusion
of CCK8 (3 pmol/min/animal). The infusion rate (0.03
ml/min animal) was held constant with a syringe pump
(Cole-Palmer). Pancreatic juice was collected in pre-
weighed vials and the secretion rate was corrected for
pancreas weight determined at the end of the experi-
ments. Pancreatic juice was also analyzed for Na+ con-
centrations by flame photometry.
The data are shown as original recordings, summaries
and mean valuesF S.E.M. To determine the statistical
significance, we used Student’s t-test, where n refers to
the number of experiments from different ducts/animals and
P < 0.05 was accepted as significant.
3. Results
In the first series of experiments, we tested the effect of
amiloride on Vbl of perfused ducts. In unstimulated ducts,
Fig. 1. Luminal amiloride has no effect on the basolateral membrane
voltage, Vbl. The figure shows an original recording of Vbl from a perfused
pancreatic duct that was stimulated with secretin (8 10 11 M). Following
the stimulation, luminal Cl concentration was decreased from 125 to 32
mM, and then after a wash of the pipette barrel containing the test solutions,
the duct was infused with 0.1 mM amiloride. Small deflections in Vbl are
due to the current injection from the luminal pipette that can be used to
monitor fractional resistance of the basolateral membrane.
Fig. 2. Benzamil has no effect on the membrane voltage, Vm. Summary of
data obtained on eight ducts where Vm was measured in whole-cell patch-
clamp recordings. The first and second controls indicate Vm just
immediately before and after benzamil additions (0.01 mM) in the same
ducts.
Fig. 3. Lowering of extracellular Na+ hyperpolarizes, and lowering of
extracellular Ca2 + depolarizes Vm. The extracellular Na
+ concentration was
lowered from 145 to 5 mM or nominal 0 mM and the substituting cation
was NMDG+. The Ca2 +-free solutions were made with EGTA. There are
13, 4 and 7 experiments in the series shown, respectively, and the asterisks
indicate that P< 0.05.
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where Vbl was about  60 mV, amiloride applied from the
basolateral side had very small effects on Vbl–depolarizing
it by 2.1F 0.6 mV (amiloride 0.1 mM) and by 3.2F 0.4 mV
(amiloride 1 mM), respectively (n = 15, 21). This is in
agreement with our earlier study, where we proposed that
this effect of amiloride is probably due to inhibition of a
Na+/H+ exchanger (NHE) and intracellular pH effect on K+
channels [23,25]. In several experiments, amiloride was
tested from the luminal side and Fig. 1 shows an original
recording of Vbl from such an experiment where the duct
was stimulated with secretin. Initially, there was a short-
lasting hyperpolarization, due to opening of basolateral K+
channels, which was quickly taken over by depolarization of
Vbl due to opening of CFTR-Cl
 channels, as described
earlier [16,25]. The Cl conductance was demonstrated by a
concentration step in the luminal Cl from 125 to 32 mM,
which further depolarized Vbl in this leaky epithelium. Most
importantly, after the low-Cl solution was washed out of
the lumen, infusion of amiloride (0.1 mM) had no detectable
effect on Vbl.
In another set of experiments, where Vm was measured in
a whole-cell nystatin technique, we tested the effect of
another Na+ channel blocker–benzamil. In these experi-
ments, duct fragments, usually from smaller ducts than
those used for perfusion, were used and the inhibitor had
access to both the luminal and basolateral sides of the
epithelium (see Materials and Methods). Fig. 2 shows the
summary of the data obtained. Benzamil (0.01 mM) had no
significant effect on Vm in eight ducts, including three ducts
that were stimulated with secretin. Thus, benzamil, like
amiloride, could not hyperpolarize the membrane voltage
of duct cells.
Fig. 3 shows the results of experiments where we
investigated the effect of low-Na+ solutions on Vm, again
Fig. 4. Low Na+ concentrations effect on Vm is inhibited in a duct stimulated with secretin. An original recording of Vm in one pancreatic duct: (A) first
unstimulated and exposed to extracellualr solution with 5 mM Na+; (B) then stimulated with secretin (10 9 M) and exposed to aldosterone (10 10 M) and
exposed to low Cl (5 mM Cl) or low Na+ (5 mM); and lastly, (C) stimulated with ATP (0.1 mM).
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measured in whole-cell nystatin recordings. A decrease in
Na+ concentrations from 145 to 5 mM hyperpolarized Vm
from  46F 3 to  52F 2 mV (Fig. 3A). With 0 mM Na+
solutions, the hyperpolarization was from  31F 8 to
 46F 5 mV (Fig. 3B). This effect could have indicated
presence of Na+ channels. However, when Li+ was used as a
substituting cation instead of NMDG+, responses were
similar (n = 3), indicating that Li+ was rather imperme-
able–unlikely for a Na+ channel [2]. Moreover, the time
course of the Vm responses was somewhat unusual for a Na
+
channel response. Often the Vm hyperpolarization was
transient, as already shown earlier [24], and there was a
transient overshoot in Vm when the duct was returned to the
control Na+ solution (Fig. 4A). In an earlier study, we
showed that such Vm transients and corresponding intra-
cellular Ca2 + changes are compatible with an electrogenic
3Na+/Ca2 + exchanger [24]. That is, when the extracellular
Na+ is lowered, the exchanger works in the Na+ efflux
mode, thus hyperpolarizing Vm. Present experiments in Fig.
3C show that a removal of extracellular Ca2 + led to
depolarization of Vm from  50F 2 to  34F 3 mV, which
could arise from influx of 3Na+ in exchange for Ca2 +
exiting the cell down its chemical gradient. These Na+
(and Ca2 +) substitution experiments are indicative of Na+/
Ca2 + exchange rather than a Na+ channel.
Nevertheless, it was important to investigate whether Na+
channels can be opened during secretin stimulation. Fig. 4
shows an original recording of Vm of a duct that was
exposed to low Na+, first in an unstimulated state (Fig.
4A) and then after being stimulated with secretin (Fig. 4B).
Secretin stimulation opened CFTR-Cl channels, again as
demonstrated by the depolarizing Vm response to low Cl
 in
the extracellular medium. Notably, the low-Na+ solution
now had no effect on Vm. Also benzamil had no effect in
this experiment (not shown). Later in the experiment (Fig.
4C), the duct was stimulated with ATP, which resulted in a
depolarization of Vm. This is due to closing of K
+ channels
and influx of Na+ and Ca2 + through different P2 purinergic
receptors [26]. Note that during secretin stimulation, Vm
became steadier, as it was dominated by the activity of many
channels (CFTR-Cl channels) and as shown earlier, the
fractional conductance of the luminal membrane increased
20-fold [20]. In contrast, during the ATP stimulation, the
recording became more ‘‘noisy’’, as the overall membrane
conductance decreased due to P2Y2/P2Y4 purinergic-medi-
ated closure of K+ channels [26]. Notably, this duct was also
exposed to aldosterone (10 10 M) together with secretin.
In some epithelia, aldosterone is able to induce acute
non-genomic effects on Na+ and other channels and NHE
(see below). Yet, in pancreatic ducts, aldosterone even after
about 30 min had no significant effect on Vm as summarized
in Fig. 5. The classical effects of mineralocorticoids are
genomic with early phase effects (0.5–1 h), and late phase
effects apparent around 3 h. Hence, in one series of experi-
ments, we compared Vbl of perfused pancreatic ducts from
animals pre-treated with DOC to control animals. Fig. 6
shows that the resting Vbl was very similar on both series. In
addition, the data show that secretin had a similar depola-
rizing effect on Vbl of both types of ducts. Thus, in ducts
from control rats, secretin depolarized Vbl by 34F 1 mV
(n = 41), and in ducts from DOC rats, the resting Vbl was
very similar and secretin depolarized Vbl by 37F 3 mV
(n = 8). These experiments show that DOC pre-treatment did
not lead to synthesis and insertion of ENaC that could be
detected in resting or stimulated ducts.
Since glucocorticoids can increase expression of ENaC
in some epithelia, for example, lung [27,28], and glucocor-
ticoids also have effects on pancreatic enzymes [29,30], we
Fig. 5. Aldosterone has no effect on Vm. Summary of experiments where
pancreatic ducts were exposed to aldosterone (10 10 M) for about 30 min
(n= 3).
Fig. 6. DOC has no effect on Vbl of unstimulated or stimulated pancreatic
ducts. Vbl was measured in perfused ducts dissected from untreated (n= 41)
and treated (n= 8) animals. The resting Vbl and that of ducts stimulated with
secretin (10 10–10 9 M) were similar in the two series of experiments. The
asterisks indicate that P< 0.05 between unstimulated and the corresponding
secretin-stimulated ducts.
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tested the effect of Dexa treatment on pancreatic secretion.
The total function of the pancreas was estimated by meas-
uring the secretory capacity of the intact pancreas in
anaesthetized animals as shown in Fig. 7. Secretion was
elicited by secretin, the main agonist of pancreatic ducts,
and subsequently by CCK8, the main agonist of pancreatic
acini. The data show that the secretory response was very
similar in both series of animals. In addition, Na+ concen-
trations in the pancreatic juice were about 155 mM and did
not change with the treatment or the secretory rate (data not
shown).
4. Discussion
The present study shows that amiloride and benzamil did
not hyperpolarize membrane voltages (Vbl or Vm) of unsti-
mulated or stimulated pancreatic ducts (Figs. 1 and 2) as one
would have expected upon inhibition of ENaC. The con-
centrations of the inhibitors used in the present study were
sufficient to block even the less sensitive hetero-oligomers
with the y-ENaC subunit [21]. In fact, amiloride caused a
small depolarization of V, which we ascribed to inhibition of
NHE, followed by intracellular pH effects on K+ channels.
This effect on V was even more pronounced with another
amiloride derivative EIPA [25].
Lowering of extracellular Na+ did hyperpolarize V (Figs.
3 and 4), as would have been expected for a Na+ channel.
However, the effect as also observed earlier, showed
unusual transients, also upon reintroduction of Na+ back
to the media, and also occurred with Li+ as the substituting
cation. These transients were accompanied by Ca2 + tran-
sients, as they were dependent on provision of extracellular
Ca2 +, and we concluded that they were due to electrogenic
Na+/Ca2 + exchanger [24]. Our present data with low Na+
and Ca2 + support these interpretations. Interestingly, the
hyperpolarizing effect of low Na+ is eliminated in ducts
stimulated with secretin (Fig. 4). In a recent study, we
showed that pancreatic ducts express two isoforms of the
Na+/Ca2 + exchanger, NXC1.3 and NCX1.7, and that secre-
tin stimulation inhibits Ca2 + transients mediated by the
exchanger [31].
Mineralocorticoid pre-treatment, either acute (Figs. 4 and
5) or longer lasting (Fig. 6), had no effect on V of resting or
stimulated ducts. Clearly, if ENaC were upregulated by any
signaling pathways including posttranslational control, or
were newly synthesized and inserted in the apical membrane
[32,33], resting and also stimulated V should have been
more depolarized. This clearly was not the case. Even
acutely ( < 1 min), there were no significant changes in V,
which indicates that there was no non-genomic activation of
Na+ and K+ channels or NHE, as seen in colon and kidney
epithelia [34].
Most importantly, the treatment of rats with glucocorti-
coids had no effect on pancreatic secretion either stimulated
with the predominantly ductal agonist secretin, or the acinar
agonist CCK8 (Fig. 7). Thus, electrolyte and fluid secretion
from the two epithelia is not affected, although glucocorti-
coids can stimulate synthesis and storage of proteins
[29,30], and although human pancreas expresses the serum-
and glucocorticoid-dependent serine/threonine kinase (sgk1)
[35] that can be involved in ENaC regulation [33]. Regard-
ing pancreatic acini, our results with CCK8 support a large
number of electrophysiological studies, which so far have
not come up with selective Na+ channels, but rather non-
selective cation channels of unknown functions [36].
Taken together, despite the fact that there might be one
or more subunits of ENaC expressed in pancreas, the
present study finds no evidence for functional Na+ channels
either in stimulated or unstimulated pancreatic ducts.
Hence, possible ENaC subunits are not assembled into a
functional channel, or the channel is down-regulated. In
fact, this lack of functional ENaC makes sense, as native
pancreatic ducts form a leaky and secretory epithelium.
Moreover, it is well established that Na+ concentrations in
pancreatic juice are plasma-like and do not change with
secretory rate.
Nevertheless, there are Na+ conductive pathways in pan-
creatic ducts that are due to a regulated Na+/Ca2 + exchanger
[24,31], and due to P2X7/P2X4 purinergic receptors that are
Ca2 +/Na+ channels when stimulated with ATP [26]. The role
of these two types of cation conductance is probably asso-
ciated with Ca2 + signaling and/or Ca2 + transport. In addition,
although rat pancreatic ducts do have a Na+/HCO3
 cotrans-
porter (NBC) [37,38], the transporter is not electrogenic in
these pancreatic ducts, as already addressed and shown in
earlier electrophysiological studies [20,23].
In conclusion, the present study on electrophysiological
responses of isolated pancreatic ducts, and secretory re-
Fig. 7. Dexa has no effect on pancreatic secretion. Pancreatic secretion was
evoked by secretin (10 pmol/min/animal) and later with CCK8 (3 pmol/
min/animal) in pancreas from control and Dexa pre-treated rats (n= 3 in
each series).
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sponses of intact pancreas shows that there are no functional
ENaC, although there is functional CFTR. This is in
accordance with the function of pancreatic ducts as a
secretory epithelium.
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